CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in ...
SYS-CON Media (press release)
Barostim neo is a second-generation device that uses CVRx-patented technology designed to trigger the body's own natural blood flow regulation system to treat patients suffering from chronic heart failure. The therapy is also a treatment option for ...

and more »


More...